scispace - formally typeset
J

John W. Erdman

Researcher at University of Illinois at Urbana–Champaign

Publications -  329
Citations -  19074

John W. Erdman is an academic researcher from University of Illinois at Urbana–Champaign. The author has contributed to research in topics: Lycopene & Carotenoid. The author has an hindex of 65, co-authored 314 publications receiving 17580 citations. Previous affiliations of John W. Erdman include University of Oklahoma Health Sciences Center & Urbana University.

Papers
More filters
Journal ArticleDOI

Lycopene and Apo-12′-Lycopenal Reduce Cell Proliferation and Alter Cell Cycle Progression in Human Prostate Cancer Cells

TL;DR: The present data indicate that lycopene and apo-12′-lycopenal reduce the proliferation of prostate cancer cells, in part, by inhibiting normal cell cycle progression.
Journal ArticleDOI

Factors influencing the uptake and absorption of carotenoids.

TL;DR: In his classic book entitled Vitamin A, Thomas Moore wrote, “There are many complicating factors, both chemical and physiological, which will make it difficult to give an account of the absorption of vitamin A and its provitamins (carotenoids) which is both clear and reasonably comprehensive (1).
Journal ArticleDOI

Apo-8′-Lycopenal and Apo-12′-Lycopenal Are Metabolic Products of Lycopene in Rat Liver

TL;DR: These data show that lycopene is cleaved in vivo by rats at different positions to produce apo-12'-lycopenal, and other unidentified metabolites in addition to apO-8'-lyCopenal.
Journal ArticleDOI

Tomato products, lycopene, and prostate cancer risk.

TL;DR: It is reasonable to recommend to the general population the consumption of tomato products at approximately one serving per day or five servings per week as part of an overall healthy dietary pattern that may reduce the risks of prostate cancer, other malignancies, or other chronic diseases.
Journal ArticleDOI

Manganese superoxide dismutase (MnSOD) gene polymorphism, interactions with carotenoid levels and prostate cancer risk

TL;DR: Findings are consistent with findings from earlier studies that reported when antioxidant status is low, the MnSOD Ala/Ala genotype may be associated with an increased risk of aggressive prostate cancer.